article thumbnail

Recognizing the Real People Behind the Big Data and Artificial Intelligence in Clinical Research

ACRP blog

If you hadn’t already noticed, the clinical research enterprise has well and truly entered the era of “big data,” artificial intelligence (AI), and machine learning. As a result, the time required to design, launch, and execute high-impact clinical trials is significantly reduced.”

article thumbnail

AI, big data and deep real-world evidence – the challenges and opportunities

pharmaphorum

This pharmaphorum webinar, held in association with Savana, will take place on Thursday 22 April from 16:00-17:00 BST / 17:00-18:00 CET / 10:00-11:00 EST and hear from presenters at BREATHE – the health data research hub for respiratory health, Salford Royal NHS Foundation Trust and Savana.

Big Data 110
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

August 16, 2023: In This Friday’s PCT Grand Rounds, the Draft Revision of the ICH Good Clinical Practice Guideline

Rethinking Clinical Trials

Landry is a professor of medicine and epidemiology at Oxford Population Health and deputy director of the University of Oxford’s Big Data Institute. ElZarrad is the director of the Office of Medical Policy in the FDA’s Center for Drug Evaluation and Research. Join the online meeting.

article thumbnail

Synthetic control arms in clinical trials: Making it happen

pharmaphorum

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?

article thumbnail

Six Benefits of Using a Mobile App in Clinical Trials

Crucial Data Soutions

A paradigm shift is occurring in the clinical trials industry surrounding mobile technology, or more specifically, mobile health (mHealth) following the COVID-19 pandemic. Organizations are beginning to recognize the power mHealth has to positively affect their clinical trials and are implementing technologies at an increasing rate.

article thumbnail

EMA pilot will see if clinical trial data should be digested ‘raw’

pharmaphorum

A pilot study has been launched by the EMA to see whether it is helpful for regulators to look at the ‘raw data’ from clinical trials submitted in support of new marketing application along with the usual structured analyses from sponsors.

article thumbnail

Medical experts note technology adoption brings in new paradigm shift in healthcare practice

AuroBlog - Aurous Healthcare Clinical Trials blog

Some of the medical advances with the technology are genomics and epigenetics, Big Data, AI and ML which are allowing molecular […] Technology adoptions like artificial intelligence and machine learning are bringing in major transformation in the way a primary physician will extend treatment protocols.

Big Data 100